Pharmafile Logo

News and Press Releases

Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes

5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...

Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024

Pill Connect
info@pill-connect.con
125 Deansgate, Manchester, M2 3BY, UK

Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer

Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...

Category: BioManufacturing
Posted: January 25, 2024

Cellular Origins
hello@cellularorigins.com
TTP Campus Cambridge Road Melbourn SG8 6HQ

Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Globally operating CDMO committed to strengthening Germany as a research and production location  Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...

Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024

Vetter
Schützenstrasse 87, 88212 Ravensburg

Additional Analytical Laboratory and Spray Drying Investments

5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...

Category: Manufacturing and Packing
Posted: October 5, 2023

Experic
info@expericservices.com
2 Clarke Drive, Cranbury, NJ 08512

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation

Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...

Category: Biotechnology
Posted: October 4, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Broken String Biosciences Closes $15m Series A Funding Round

Funds to support further development and commercialisation of the company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression...

Category: Biotechnology
Posted: September 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR